Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
Business Wire
22h
Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapav…
Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Advance to World Series
Reaches tentative union deal
Boat rider arrested in FL
Postpones US tour
Hurricane Oscar forms
MS after game shooting
Baldwin returns to 'SNL'
Probes near miss in Austin
Trump's Pennsylvania rally
NYC Halloween dog parade
Rock & Roll HOF '24 class
US probing documents leak
Philip Zimbardo dies at 91
CVS workers strike
US deficit reaches $1.8T
Ferry dock collapses in GA
ISR strikes northern Gaza
Opioid suits settlement deal
Antitrust ruling delayed
Orionids meteor shower
Ex-MN congressman dies
G7 ministers back Ukraine
Challenges military listing
Launches OneWeb mission
Georgia beats Texas
Urges support for Ukraine
Opens up on Russian camp
Bladder cancer drug pulled
Oakland fire burns homes
Frozen waffles recalled
Feedback